Senior Director Global Commercial Lung Cancer
AstraZeneca
Summary
As Sr Director, Global Commercial, Lung Cancer you will play a pivotal role in channeling our scientific capabilities to make a positive impact on changing the lives of people with lung cancer. Our Global Commercial Oncology organization shapes the AstraZeneca has a deep-rooted heritage in Oncology and offers a quickly-growing portfolio of new medicines that has the potential to transform patients’ lives and the Company’s future. By harnessing the power of four scientific platforms - Immuno-Oncology, Tumor Drivers and Resistance, DNA Damage Response, and Antibody Drug Conjugates - and by championing the development of personalized combinations, AstraZeneca has the vision to redefine cancer treatment and one day eliminate cancer as a cause of death.
Job description
Role Description
The Sr Director, Global Commercial, Lung Cancer will be part of the Lung Cancer Tumor Strategy and Commercialization team within the Global Datroway and Lung Cancer Franchise. AstraZeneca has an industry leading portfolio of in-market and pipeline products focused on transforming care and improving patient outcomes in lung cancer, and as part of the Global Lung Cancer Franchise Team, you will be integral to our collective efforts towards transforming care for lung cancer patients globally.
The role will report into the VP, Franchise Head, Datroway and Lung Cancer, and will support the development and execution of above-asset tumor strategic commercial initiatives in support of our global lung cancer commercialization priorities.
This position will be based in Gaithersburg, MD.
Key Accountabilities
- Lead the development and execution of strategic marketing and commercialization initiatives associated with the lung cancer Tumor Leadership Plan (TLP)
- Global lead for tumor level initiatives to improve Quality of Care (QoC) in lung cancer, in alignment with Tumor Leadership Plan and Lung Ambition Alliance QoC strategic objectives
- Tumor lead for key strategic engagement initiatives with Global Lung KEEs and Professional Societies
- Lead the strategic development and execution of initiatives to enhance Multi-Disciplinary Team coordination in lung cancer
- Partner with Medical Affairs Team to deliver tumor level cross-functional priorities (e.g: Lung scientific summit, evidence generation initiatives)
- Partner with patient affairs to build patient support initiatives aimed at improving overall quality of care in Lung Cancer
- Champion and serve as business lead for relevant digital initiatives in support of improving quality of care in Lung Cancer
- Partner closely with brand and indication teams to ensure alignment of above-asset initiatives with brand led initiatives
- Engage effectively with Region/Country teams and ensure global deliverables meet market needs
- Collaborate closely and influence cross-functional partners (e.g. Insights, Access, Medical, Sales, Training, Corporate Affairs) in support of tumor strategic/operational plans
- Develop and deliver key brand presentations to leadership
- Manage agency relationships, workflow, and commercial budget
Qualifications
Minimum qualifications
- Bachelor's Degree in relevant field
- 10+ years’ experience in pharmaceutical and/or healthcare industry with experience in one or more of the following: brand marketing, sales, market research/analytics, strategic planning
- Prior oncology in-line HCP marketing experience within a major market
- Experience building and integrating new capabilities to drive leadership in customer engagement and impact
Preferred qualifications
- MBA in relevant field
- In-depth experience leading broad strategic marketing initiatives
- Experience across multiple promotional channels (Personal, Non-Personal and Digital, Patient marketing)
- Prior global marketing experience
- Sales/Customer-facing experience
- Launch experience
- Management experience
Skills
- Excellent oral and written communication skills, with ability to clearly and concisely communicate complex constructs
- Ability to manage complex projects
- Demonstrated ability to work in matrixed environment and to work with Global team
- Strong business acumen skills
- Ability to lead without authority
- High capability at working collaboratively, thinking strategically, and operating effectively in a rapidly evolving and competitive market-place
- High ethical standards and personal integrity
Requirements
- Bachelor's Degree in relevant field
- 10+ years’ experience in pharmaceutical and/or healthcare industry
- Experience in brand marketing, sales, market research/analytics, or strategic planning
- Prior oncology in-line HCP marketing experience within a major market
- Experience building and integrating new capabilities to drive leadership in customer engagement and impact
- Excellent oral and written communication skills
- Ability to manage complex projects
- Demonstrated ability to work in matrixed environment and to work with Global team
- Strong business acumen skills
- Ability to lead without authority
- High capability at working collaboratively, thinking strategically, and operating effectively in a rapidly evolving and competitive market-place
- High ethical standards and personal integrity
Benefits
- 401(k) plan
- Paid vacation
- Paid holidays
- Paid leaves
- Medical insurance
- Prescription drug coverage
- Dental insurance
- Vision coverage
- Short-term incentive bonus
- Equity-based long-term incentive program
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.